Recce Pharmaceuticals Ltd
ASX:RCE

Watchlist Manager
Recce Pharmaceuticals Ltd Logo
Recce Pharmaceuticals Ltd
ASX:RCE
Watchlist
Price: 0.32 AUD 3.23% Market Closed
Market Cap: 83.8m AUD

Wall Street
Price Targets

RCE Price Targets Summary
Recce Pharmaceuticals Ltd

There are no price targets for RCE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Recce Pharmaceuticals Ltd Competitors:
Price Targets
600085
Beijing Tongrentang Co Ltd
26% Upside
LINCOLN
Lincoln Pharmaceuticals Ltd
82% Upside
MYX
Mayne Pharma Group Ltd
45% Upside
TBPH
Theravance Biopharma Inc
55% Upside
2096
Simcere Pharmaceutical Group Ltd
4% Downside
SECARE
Swedencare AB (publ)
16% Upside
ERIS
Eris Lifesciences Ltd
1% Downside
4569
Kyorin Holdings Inc
1% Downside

Revenue
Forecast

Revenue Estimate
Recce Pharmaceuticals Ltd

For the last 8 years the compound annual growth rate for Recce Pharmaceuticals Ltd's revenue is 53%. The projected CAGR for the next 3 years is -13%.

53%
Past Growth
-13%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Recce Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Recce Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RCE's stock price target?
Not Available

RCE doesn't have any price targets made by Wall Street professionals.

What is Recce Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
-13%

For the last 8 years the compound annual growth rate for Recce Pharmaceuticals Ltd's revenue is 53%. The projected CAGR for the next 3 years is -13%.

Back to Top